{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:13:58Z","timestamp":1768565638732,"version":"3.49.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T00:00:00Z","timestamp":1512000000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Korea Health Technology R&D project","award":["HI14C0175"],"award-info":[{"award-number":["HI14C0175"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00784-017-2291-z","type":"journal-article","created":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T02:32:49Z","timestamp":1512009169000},"page":"1933-1943","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Bisphosphonates hinder osteoblastic\/osteoclastic differentiation in the maxillary sinus mucosa-derived stem cells"],"prefix":"10.1007","volume":"22","author":[{"given":"Jun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaesuh","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Dae","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8445-2594","authenticated-orcid":false,"given":"Eun-Cheol","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,30]]},"reference":[{"issue":"1","key":"2291_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S8756-3282(99)00116-7","volume":"25","author":"RG Russell","year":"1999","unstructured":"Russell RG, Rogers MJ (1999) Bisphosphonates: from the laboratory to the clinic and back again. Bone 25(1):97\u2013106. https:\/\/doi.org\/10.1016\/S8756-3282(99)00116-7","journal-title":"Bone"},{"issue":"7","key":"2291_CR2","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1073\/pnas.96.7.3540","volume":"96","author":"H Hsu","year":"1999","unstructured":"Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, Wang L, Xia XZ, Elliott R, Chiu L, Black T, Scully S, Capparelli C, Morony S, Shimamoto G, Bass MB, Boyle WJ (1999) Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci U S A 96(7):3540\u20133545. https:\/\/doi.org\/10.1073\/pnas.96.7.3540","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2291_CR3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1177\/154405910408300216","volume":"83","author":"M Mogi","year":"2004","unstructured":"Mogi M, Otogoto J, Ota N, Togari A (2004) Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. J Dent Res 83(2):166\u2013169. https:\/\/doi.org\/10.1177\/154405910408300216","journal-title":"J Dent Res"},{"issue":"1-2","key":"2291_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11154-006-9009-x","volume":"7","author":"A Bruzzaniti","year":"2006","unstructured":"Bruzzaniti A, Baron R (2006) Molecular regulation of osteoclast activity. Rev Endocr Metab Disord 7(1-2):123\u2013139. https:\/\/doi.org\/10.1007\/s11154-006-9009-x","journal-title":"Rev Endocr Metab Disord"},{"issue":"2","key":"2291_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S0002-9343(99)80134-X","volume":"99","author":"CH Chesnut","year":"1995","unstructured":"Chesnut CH, McClung MR, Ensrud KE et al (1995) Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling. Am J Med 99(2):144\u2013152. https:\/\/doi.org\/10.1016\/S0002-9343(99)80134-X","journal-title":"Am J Med"},{"issue":"2","key":"2291_CR6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0022-3565(24)38786-5","volume":"296","author":"JE Dunford","year":"2001","unstructured":"Dunford JE, Thompson K, Coxon FP, Luckman SP, Hahn FM, Poulter CD, Ebetino FH, Rogers MJ (2001) Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther 296(2):235\u2013242","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"2291_CR7","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1054\/bjoc.2000.1679","volume":"84","author":"PS Mackie","year":"2001","unstructured":"Mackie PS, Fisher JL, Zhou H, Choong PF (2001) Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line. Br J Cancer 84(7):951\u2013958. https:\/\/doi.org\/10.1054\/bjoc.2000.1679","journal-title":"Br J Cancer"},{"issue":"5","key":"2291_CR8","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00198-005-0035-4","volume":"17","author":"H Dobnig","year":"2006","unstructured":"Dobnig H, Hofbauer LC, Viereck V, Obermayer-Pietsch B, Fahrleitner-Pammer A (2006) Changes in the RANK ligand\/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients. Osteoporos Int 17(5):693\u2013703. https:\/\/doi.org\/10.1007\/s00198-005-0035-4","journal-title":"Osteoporos Int"},{"issue":"3","key":"2291_CR9","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1006\/bbrc.2002.6510","volume":"291","author":"V Viereck","year":"2002","unstructured":"Viereck V, Emons G, Lauck V, Frosch KH, Blaschke S, Grundker C, Hofbauer LC (2002) Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts. Biochem Biophys Res Commun 291(3):680\u2013686. https:\/\/doi.org\/10.1006\/bbrc.2002.6510","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2291_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/emm.2002.21","volume":"34","author":"YH Kim","year":"2002","unstructured":"Kim YH, Kim GS, Baek JH (2002) Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression. Exp Mol Med 34(2):145\u2013151. https:\/\/doi.org\/10.1038\/emm.2002.21","journal-title":"Exp Mol Med"},{"issue":"1","key":"2291_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1359\/jbmr.2004.19.1.147","volume":"19","author":"B Pan","year":"2004","unstructured":"Pan B, Farrugia AN, To LB, Findlay DM, Green J, Lynch K, Zannettino AC (2004) The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE). J Bone Miner Res 19(1):147\u2013154. https:\/\/doi.org\/10.1359\/jbmr.2004.19.1.147","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2291_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ijom.2004.09.009","volume":"34","author":"M Hallman","year":"2005","unstructured":"Hallman M, Sennerby L, Zetterqvist L, Lundgren S (2005) A 3-year prospective follow-up study of implant-supported fixed prostheses in patients subjected to maxillary sinus floor augmentation with a 80:20 mixture of deproteinized bovine bone and autogenous bone clinical, radiographic and resonance frequency analysis. Int J Oral Maxillofac Surg 34(3):273\u2013280. https:\/\/doi.org\/10.1016\/j.ijom.2004.09.009","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"3","key":"2291_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1708-8208.2004.tb00224.x","volume":"6","author":"S Lundgren","year":"2004","unstructured":"Lundgren S, Andersson S, Gualini F, Sennerby L (2004) Bone reformation with sinus membrane elevation: a new surgical technique for maxillary sinus floor augmentation. Clin Implant Dent Relat Res 6(3):165\u2013173. https:\/\/doi.org\/10.1111\/j.1708-8208.2004.tb00224.x","journal-title":"Clin Implant Dent Relat Res"},{"issue":"2","key":"2291_CR14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s00223-008-9202-x","volume":"84","author":"S Srouji","year":"2009","unstructured":"Srouji S, Kizhner T, Ben David D, Riminucci M, Bianco P, Livne E (2009) The Schneiderian membrane contains osteoprogenitor cells: in vivo and in vitro study. Calcif Tissue Int 84(2):138\u2013145. https:\/\/doi.org\/10.1007\/s00223-008-9202-x","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"2291_CR15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1600-0501.2004.01062.x","volume":"15","author":"R Gruber","year":"2004","unstructured":"Gruber R, Kandler B, Fuerst G, Fischer MB, Watzek G (2004) Porcine sinus mucosa holds cells that respond to bone morphogenetic protein (BMP)-6 and BMP-7 with increased osteogenic differentiation in vitro. Clin Oral Implants Res 15(5):575\u2013580. https:\/\/doi.org\/10.1111\/j.1600-0501.2004.01062.x","journal-title":"Clin Oral Implants Res"},{"issue":"9","key":"2291_CR16","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1002\/jcp.24022","volume":"227","author":"A Graziano","year":"2012","unstructured":"Graziano A, Benedetti L, Massei G, Cusella de Angelis MG, Ferrarotti F, Aimetti M (2012) Bone production by human maxillary sinus mucosa cells. J Cell Physiol 227(9):3278\u20133281. https:\/\/doi.org\/10.1002\/jcp.24022","journal-title":"J Cell Physiol"},{"issue":"24","key":"2291_CR17","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1016\/j.biomaterials.2007.04.024","volume":"28","author":"F Knoch von","year":"2007","unstructured":"von Knoch F, Eckhardt C, Alabre CI, Schneider E, Rubash HE, Shanbhag AS (2007) Anabolic effects of bisphosphonates on peri-implant bone stock. Biomaterials 28(24):3549\u20133559. https:\/\/doi.org\/10.1016\/j.biomaterials.2007.04.024","journal-title":"Biomaterials"},{"issue":"3","key":"2291_CR18","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.joms.2009.07.066","volume":"68","author":"A Yildiz","year":"2010","unstructured":"Yildiz A, Esen E, Kurkcu M, Damlar I, Daglioglu K, Akova T (2010) Effect of zoledronic acid on osseointegration of titanium implants: an experimental study in an ovariectomized rabbit model. J Oral Maxillofac Surg 68(3):515\u2013523. https:\/\/doi.org\/10.1016\/j.joms.2009.07.066","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"2291_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1902\/jop.2005.76.1.107","volume":"76","author":"PM Duarte","year":"2005","unstructured":"Duarte PM, de Vasconcelos Gurgel BC, Sallum AW, Filho GR, Sallum EA, Nociti FH Jr (2005) Alendronate therapy may be effective in the prevention of bone loss around titanium implants inserted in estrogen-deficient rats. J Periodontol 76(1):107\u2013114. https:\/\/doi.org\/10.1902\/jop.2005.76.1.107","journal-title":"J Periodontol"},{"issue":"1","key":"2291_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/ID.0000000000000005","volume":"23","author":"JW Kim","year":"2014","unstructured":"Kim JW, Kwon TG (2014) Bisphosphonate-related osteonecrosis of the jaw at a previously grafted sinus. Implant Dent 23(1):18\u201321. https:\/\/doi.org\/10.1097\/ID.0000000000000005","journal-title":"Implant Dent"},{"issue":"1","key":"2291_CR21","first-page":"74","volume":"10","author":"WJ Starck","year":"1995","unstructured":"Starck WJ, Epker BN (1995) Failure of osseointegrated dental implants after diphosphonate therapy for osteoporosis: a case report. Int J Oral Maxillofac Implants 10(1):74\u201378","journal-title":"Int J Oral Maxillofac Implants"},{"issue":"5","key":"2291_CR22","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.joms.2007.12.040","volume":"66","author":"BM Bell","year":"2008","unstructured":"Bell BM, Bell RE (2008) Oral bisphosphonates and dental implants: a retrospective study. J Oral Maxillofac Surg 66(5):1022\u20131024. https:\/\/doi.org\/10.1016\/j.joms.2007.12.040","journal-title":"J Oral Maxillofac Surg"},{"issue":"10","key":"2291_CR23","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/jbmr.5650101008","volume":"10","author":"DE Hughes","year":"1995","unstructured":"Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman GD, Mundy GR, Boyce BF (1995) Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10(10):1478\u20131487. https:\/\/doi.org\/10.1002\/jbmr.5650101008","journal-title":"J Bone Miner Res"},{"issue":"34","key":"2291_CR24","doi-asserted-by":"publisher","first-page":"6941","DOI":"10.1016\/j.biomaterials.2005.04.059","volume":"26","author":"F Knoch von","year":"2005","unstructured":"von Knoch F, Jaquiery C, Kowalsky M, Schaeren S, Alabre C, Martin I, Rubash HE, Shanbhag AS (2005) Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells. Biomaterials 26(34):6941\u20136949. https:\/\/doi.org\/10.1016\/j.biomaterials.2005.04.059","journal-title":"Biomaterials"},{"issue":"4","key":"2291_CR25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11154-010-9153-1","volume":"11","author":"EF Eriksen","year":"2010","unstructured":"Eriksen EF (2010) Cellular mechanisms of bone remodeling. Rev Endocr Metab Disord 11(4):219\u2013227. https:\/\/doi.org\/10.1007\/s11154-010-9153-1","journal-title":"Rev Endocr Metab Disord"},{"issue":"2","key":"2291_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1754-4505.2009.00128.x","volume":"30","author":"P Narongroeknawin","year":"2010","unstructured":"Narongroeknawin P, Danila MI, Humphreys LG Jr, Barasch A, Curtis JR (2010) Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report. Spec Care Dentist 30(2):77\u201382. https:\/\/doi.org\/10.1111\/j.1754-4505.2009.00128.x","journal-title":"Spec Care Dentist"},{"issue":"21","key":"2291_CR27","first-page":"6001","volume":"60","author":"GG Reinholz","year":"2000","unstructured":"Reinholz GG, Getz B, Pederson L, Sanders ES, Subramaniam M, Ingle JN, Spelsberg TC (2000) Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Res 60(21):6001\u20136007","journal-title":"Cancer Res"},{"issue":"1","key":"2291_CR28","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.bone.2003.08.013","volume":"34","author":"B Pan","year":"2004","unstructured":"Pan B, To LB, Farrugia AN et al (2004) The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro. Bone 34(1):112\u2013123. https:\/\/doi.org\/10.1016\/j.bone.2003.08.013","journal-title":"Bone"},{"issue":"6","key":"2291_CR29","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1172\/JCI115539","volume":"88","author":"M Sato","year":"1991","unstructured":"Sato M, Grasser W, Endo N, Akins R, Simmons H, Thompson DD, Golub E, Rodan GA (1991) Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest 88(6):2095\u20132105. https:\/\/doi.org\/10.1172\/JCI115539","journal-title":"J Clin Invest"},{"issue":"11","key":"2291_CR30","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1177\/009127002762491316","volume":"42","author":"T Chen","year":"2002","unstructured":"Chen T, Berenson J, Vescio R, Swift R, Gilchick A, Goodin S, LoRusso P, Ma P, Ravera C, Deckert F, Schran H, Seaman J, Skerjanec A (2002) Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases. J Clin Pharmacol 42(11):1228\u20131236. https:\/\/doi.org\/10.1177\/009127002762491316","journal-title":"J Clin Pharmacol"},{"issue":"9","key":"2291_CR31","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/j.1600-0714.2012.01154.x","volume":"41","author":"S Patntirapong","year":"2012","unstructured":"Patntirapong S, Singhatanadgit W, Chanruangvanit C, Lavanrattanakul K, Satravaha Y (2012) Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition. J Oral Pathol Med 41(9):713\u2013720. https:\/\/doi.org\/10.1111\/j.1600-0714.2012.01154.x","journal-title":"J Oral Pathol Med"},{"issue":"3","key":"2291_CR32","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1177\/0022034511432170","volume":"91","author":"E Shimizu","year":"2012","unstructured":"Shimizu E, Tamasi J, Partridge NC (2012) Alendronate affects osteoblast functions by crosstalk through EphrinB1-EphB. J Dent Res 91(3):268\u2013274. https:\/\/doi.org\/10.1177\/0022034511432170","journal-title":"J Dent Res"},{"issue":"6","key":"2291_CR33","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1159\/000351194","volume":"59","author":"FG Basso","year":"2013","unstructured":"Basso FG, Silveira Turrioni AP, Hebling J, de Souza Costa CA (2013) Zoledronic acid inhibits human osteoblast activities. Gerontology 59(6):534\u2013541. https:\/\/doi.org\/10.1159\/000351194","journal-title":"Gerontology"},{"issue":"10","key":"2291_CR34","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1055\/s-0030-1249084","volume":"118","author":"Y Inoue","year":"2010","unstructured":"Inoue Y, Hisa I, Seino S, Kaji H (2010) Alendronate induces mineralization in mouse osteoblastic MC3T3-E1 cells: regulation of mineralization-related genes. Exp Clin Endocrinol Diabetes 118(10):719\u2013723. https:\/\/doi.org\/10.1055\/s-0030-1249084","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"2291_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1359\/jbmr.070906","volume":"23","author":"RR Recker","year":"2008","unstructured":"Recker RR, Delmas PD, Halse J, Reid IR, Boonen S, Garc\u00eda-Hernandez PA, Supronik J, Lewiecki EM, Ochoa L, Miller P, Hu H, Mesenbrink P, Hartl F, Gasser J, Eriksen EF (2008) Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure. J Bone Miner Res 23(1):6\u201316. https:\/\/doi.org\/10.1359\/jbmr.070906","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2291_CR36","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s00223-011-9473-5","volume":"88","author":"B Eslami","year":"2011","unstructured":"Eslami B, Zhou S, Van Eekeren I, LeBoff MS, Glowacki J (2011) Reduced osteoclastogenesis and RANKL expression in marrow from women taking alendronate. Calcif Tissue Int 88(4):272\u2013280. https:\/\/doi.org\/10.1007\/s00223-011-9473-5","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"2291_CR37","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1073\/pnas.96.1.133","volume":"96","author":"JE Fisher","year":"1999","unstructured":"Fisher JE, Rogers MJ, Halasy JM, Luckman SP, Hughes DE, Masarachia PJ, Wesolowski G, Russell RGG, Rodan GA, Reszka AA (1999) Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci U S A 96(1):133\u2013138. https:\/\/doi.org\/10.1073\/pnas.96.1.133","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2291_CR38","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/hon.819","volume":"25","author":"A Allegra","year":"2007","unstructured":"Allegra A, Oteri G, Nastro E, Alonci A, Bellomo G, del Fabro V, Quartarone E, Alati C, de Ponte FS, Cicci\u00f9 D, Musolino C (2007) Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells. Hematol Oncol 25(4):164\u2013169. https:\/\/doi.org\/10.1002\/hon.819","journal-title":"Hematol Oncol"},{"issue":"5","key":"2291_CR39","first-page":"1080","volume":"8","author":"D Santini","year":"2002","unstructured":"Santini D, Vincenzi B, Avvisati G, Dicuonzo G, Battistoni F, Gavasci M, Salerno A, Denaro V, Tonini G (2002) Pamidronate induces modifications of circulating angiogenetic factors in cancer patients. Clin Cancer Res 8(5):1080\u20131084","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2291_CR40","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jss.2008.01.031","volume":"151","author":"J Yamada","year":"2009","unstructured":"Yamada J, Tsuno NH, Kitayama J, Tsuchiya T, Yoneyama S, Asakage M, Okaji Y, Shuno Y, Nishikawa T, Tanaka J, Takahashi K, Nagawa H (2009) Anti-angiogenic property of zoledronic acid by inhibition of endothelial progenitor cell differentiation. J Surg Res 151(1):115\u2013120. https:\/\/doi.org\/10.1016\/j.jss.2008.01.031","journal-title":"J Surg Res"},{"issue":"3","key":"2291_CR41","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1124\/jpet.102.035295","volume":"302","author":"J Wood","year":"2002","unstructured":"Wood J, Bonjean K, Ruetz S, Bellahc\u00e8ne A, Devy L, Foidart JM, Castronovo V, Green JR (2002) Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 302(3):1055\u20131061. https:\/\/doi.org\/10.1124\/jpet.102.035295","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"2291_CR42","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1172\/JCI200422087","volume":"114","author":"E Giraudo","year":"2004","unstructured":"Giraudo E, Inoue M, Hanahan D (2004) An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest 114(5):623\u2013633. https:\/\/doi.org\/10.1172\/JCI200422087","journal-title":"J Clin Invest"},{"issue":"7","key":"2291_CR43","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00784-014-1394-z","volume":"19","author":"AM Pabst","year":"2015","unstructured":"Pabst AM, Kr\u00fcger M, Ziebart T, Jacobs C, Walter C (2015) Isoprenoid geranylgeraniol: the influence on cell characteristics of endothelial progenitor cells after bisphosphonate therapy in vitro. Clin Oral Investig 19(7):1625\u20131633. https:\/\/doi.org\/10.1007\/s00784-014-1394-z","journal-title":"Clin Oral Investig"},{"issue":"2","key":"2291_CR44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000313787","volume":"124","author":"A Allegra","year":"2010","unstructured":"Allegra A, Alonci A, Penna G, Granata A, Nastro Siniscalchi E, Oteri G, Loddo S, Teti D, Cicci\u00f9 D, de Ponte FS, Musolino C (2010) Bisphosphonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws. Acta Haematol 124(2):79\u201385. https:\/\/doi.org\/10.1159\/000313787","journal-title":"Acta Haematol"},{"issue":"1","key":"2291_CR45","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/cncr.21104","volume":"104","author":"A Corso","year":"2005","unstructured":"Corso A, Ferretti E, Lunghi M, Zappasodi P, Mangiacavalli S, de Amici M, Rusconi C, Varettoni M, Lazzarino M (2005) Zoledronic acid down-regulates adhesion molecules of bone marrow stromal cells in multiple myeloma: a possible mechanism for its antitumor effect. Cancer 104(1):118\u2013125. https:\/\/doi.org\/10.1002\/cncr.21104","journal-title":"Cancer"},{"issue":"1","key":"2291_CR46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.tripleo.2008.03.036","volume":"106","author":"A Naidu","year":"2008","unstructured":"Naidu A, Dechow PC, Spears R, Wright JM, Kessler HP, Opperman LA (2008) The effects of bisphosphonates on osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106(1):5\u201313. https:\/\/doi.org\/10.1016\/j.tripleo.2008.03.036","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"5","key":"2291_CR47","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.bcp.2006.09.031","volume":"73","author":"MF Moreau","year":"2007","unstructured":"Moreau MF, Guillet C, Massin P, Chevalier S, Hascan H, Basle MF, Chappard D (2007) Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro. Biochem Pharmacol 73(5):718\u2013723. https:\/\/doi.org\/10.1016\/j.bcp.2006.09.031","journal-title":"Biochem Pharmacol"},{"issue":"45","key":"2291_CR48","first-page":"145","volume":"9","author":"JD Amaral","year":"2010","unstructured":"Amaral JD, Xavier JM, Steer CJ, Rodrigues CM (2010) The role of p53 in apoptosis. Discov Med 9(45):145\u2013152","journal-title":"Discov Med"},{"issue":"7","key":"2291_CR49","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1242\/jcs.02883","volume":"119","author":"GJ Spencer","year":"2006","unstructured":"Spencer GJ, Utting JC, Etheridge SL, Arnett TR, Genever PG (2006) Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro. J Cell Sci 119(7):1283\u20131296. https:\/\/doi.org\/10.1242\/jcs.02883","journal-title":"J Cell Sci"},{"issue":"4","key":"2291_CR50","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/BOR.0b013e32816e06f9","volume":"19","author":"ML Johnson","year":"2007","unstructured":"Johnson ML, Kamel MA (2007) The Wnt signaling pathway and bone metabolism. Curr Opin Rheumatol 19(4):376\u2013382. https:\/\/doi.org\/10.1097\/BOR.0b013e32816e06f9","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"2291_CR51","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/etm.2014.1676","volume":"8","author":"N Zhu","year":"2014","unstructured":"Zhu N, Qin L, Luo Z, Guo Q, Yang L, Liao D (2014) Challenging role of Wnt5a and its signaling pathway in cancer metastasis (review). Exp Ther Med 8(1):3\u20138. https:\/\/doi.org\/10.3892\/etm.2014.1676","journal-title":"Exp Ther Med"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00784-017-2291-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-017-2291-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-017-2291-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T20:55:57Z","timestamp":1751057757000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00784-017-2291-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,30]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["2291"],"URL":"https:\/\/doi.org\/10.1007\/s00784-017-2291-z","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,30]]}}}